CORRELIA BIOSYSTEMS, INC.

BERKELEY, CA · Medtech · Private

Rapid, automated point-of-care diagnostic platform for quantitative detection of Hepatitis C core antigen using novel hydrogel-based assay technology

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Headquarters: BERKELEY, CA
Latest Form D: $1.3M, May 2023
Total capital: $11.3M

Federal grants: $449K; 2 awards · 2015–2016; Rank in peer group#262 of 445
Private capital raised: $10.8M; 2 Form D · last May 2023; 42 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 13 pending

Capital timeline

Latest events

May 2023Private capital raisedForm D · SEC · 2nd filing$1.3M
Oct 2020Private capital raisedForm D · SEC · 1st filing$9.6M
Sep 2016Federal grantHealth and Human S · Phase I · Rapid assay platform for POC Hepatitis C core antigen testing$224K
Jun 2015Federal grantHealth and Human S · Phase I · Electrokinetic Lateral Flow Tests for Rapid Point-of-Care Diagnosis of Sickle Cel$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

64months

from CORRELIA BIOSYSTEMS, INC.’s first federal award to its first private round.

First federal award · Jun 2015: Health and Human S · $225K
First Form D · Oct 2020: $9.6M · 1st Form D
Awards before first raise: 2 awards

An association in public records, not a cause or a prediction.

Standing among 445 peers

Line = median

Medtech · Device

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Akwasi AporiResearcherExecutive Officer, DirectorLinked by $225K in grants as PI
Kittu KolluriDirectorNamed in SEC Form D filings
Kursad ArazDirectorNamed in SEC Form D filings
Samuel TiaDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 13

May 1, 2025PendingAutomated Analyte Measurement Systems And Kits For Use TherewithUSPTOApplication 18835321
May 1, 2025PendingSystem Modules For Use With Fluid Sample Processing SystemsUSPTOApplication 18835324
May 4, 2023PendingAutomated Analyte Measurement Systems And Kits For Use TherewithUSPTOApplication 17794978

Show all 13 patent records

Automated Analyte Measurement Systems And Kits For Use TherewithMay 1, 2025 · Application 18835321Pending
System Modules For Use With Fluid Sample Processing SystemsMay 1, 2025 · Application 18835324Pending
Automated Analyte Measurement Systems And Kits For Use TherewithMay 4, 2023 · Application 17794978Pending
Automated Analyte Measurement Systems And Kits For Use TherewithApplication PCTUS2023012340Pending
Fluid Removal For Fluid Sample Processing SystemsApplication 63355998Pending
Automated Analyte Measurement Systems And Kits For Use TherewithApplication 63306467Pending
System Modules For Use With Fluid Sample Processing SystemsApplication 63306427Pending
Automated Analyte Measurement Systems And Kits For Use TherewithApplication PCTUS2021014800Pending
Kits For Automated Analyte Measurement SystemsApplication 62965729Pending
Fluid Removal For Fluid Sample Processing SystemsApplication 18879636Pending
Automated Analyte Measurement System With Direct Sampling CapabilitiesApplication 62965725Pending
Fluid Removal For Fluid Sample Processing SystemsApplication PCTUS2023026376Pending
System Modules For Use With Fluid Sample Processing SystemsApplication PCTUS2023012326Pending

PERCEPTIMED, INC.Similar federal contract value in Medtech · null in contracts
MOBIUS BIOTECH LLCSimilar federal contract value in Medtech · null in contracts
PIROUETTE MEDICALSimilar federal contract value in Medtech · null in contracts
ELEMENTS ENDOSCOPY INCSimilar federal contract value in Medtech · null in contracts
Verthermia Inc.Similar federal contract value in Medtech · null in contracts
ALTO NEUROSCIENCE, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.